JP2016521555A5 - - Google Patents

Info

Publication number

JP2016521555A5

JP2016521555A5 JP2016518017A JP2016518017A JP2016521555A5 JP 2016521555 A5 JP2016521555 A5 JP 2016521555A5 JP 2016518017 A JP2016518017 A JP 2016518017A JP 2016518017 A JP2016518017 A JP 2016518017A JP 2016521555 A5 JP2016521555 A5 JP 2016521555A5

Authority

JP

Japan

Prior art keywords

composition

gene

grna

expression

dystrophin gene

Prior art date

2014-06-05

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 108020005004 Guide RNA Proteins 0.000 claims description 117
• 108090000623 proteins and genes Proteins 0.000 claims description 103
• 108091033409 CRISPR Proteins 0.000 claims description 66
• 230000008685 targeting Effects 0.000 claims description 61
• 108010069091 Dystrophin Proteins 0.000 claims description 51
• 108020004414 DNA Proteins 0.000 claims description 43
• 239000000203 mixture Substances 0.000 claims description 43
• 239000013598 vector Substances 0.000 claims description 41
• 238000012217 deletion Methods 0.000 claims description 32
• 230000037430 deletion Effects 0.000 claims description 32
• 102000040430 polynucleotide Human genes 0.000 claims description 23
• 108091033319 polynucleotide Proteins 0.000 claims description 23
• 239000002157 polynucleotide Substances 0.000 claims description 23
• 241001465754 Metazoa Species 0.000 claims description 22
• 101710163270 Nuclease Proteins 0.000 claims description 20
• 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 claims description 18
• 230000004048 modification Effects 0.000 claims description 18
• 238000012986 modification Methods 0.000 claims description 18
• 210000002027 skeletal muscle Anatomy 0.000 claims description 18
• 210000003205 muscle Anatomy 0.000 claims description 17
• 238000010362 genome editing Methods 0.000 claims description 14
• 108020005067 RNA Splice Sites Proteins 0.000 claims description 11
• 108020004705 Codon Proteins 0.000 claims description 9
• 230000002159 abnormal effect Effects 0.000 claims description 8
• 230000001404 mediated effect Effects 0.000 claims description 8
• 210000004165 myocardium Anatomy 0.000 claims description 8
• 230000037433 frameshift Effects 0.000 claims description 6
• 238000011144 upstream manufacturing Methods 0.000 claims description 6
• 230000034431 double-strand break repair via homologous recombination Effects 0.000 claims description 5
• 231100000221 frame shift mutation induction Toxicity 0.000 claims description 3
• 239000002773 nucleotide Substances 0.000 claims description 3
• 125000003729 nucleotide group Chemical group 0.000 claims description 3
• 239000013607 AAV vector Substances 0.000 claims description 2
• 241000702421 Dependoparvovirus Species 0.000 claims description 2
• 208000026350 Inborn Genetic disease Diseases 0.000 claims description 2
• 108020004485 Nonsense Codon Proteins 0.000 claims description 2
• 230000000747 cardiac effect Effects 0.000 claims description 2
• 238000012224 gene deletion Methods 0.000 claims description 2
• 208000016361 genetic disease Diseases 0.000 claims description 2
• 208000016334 muscle symptom Diseases 0.000 claims description 2
• 230000005100 tissue tropism Effects 0.000 claims description 2
• 210000004027 cell Anatomy 0.000 description 101
• 238000000034 method Methods 0.000 description 86
• 230000014509 gene expression Effects 0.000 description 62
• 108091027544 Subgenomic mRNA Proteins 0.000 description 54
• 230000004913 activation Effects 0.000 description 26
• 108020001507 fusion proteins Proteins 0.000 description 26
• 102000037865 fusion proteins Human genes 0.000 description 26
• 101001053946 Homo sapiens Dystrophin Proteins 0.000 description 23
• 210000003098 myoblast Anatomy 0.000 description 23
• 239000013613 expression plasmid Substances 0.000 description 22
• 102000001039 Dystrophin Human genes 0.000 description 21
• 238000010354 CRISPR gene editing Methods 0.000 description 19
• 101000901099 Homo sapiens Achaete-scute homolog 1 Proteins 0.000 description 19
• 230000000694 effects Effects 0.000 description 19
• 102100022142 Achaete-scute homolog 1 Human genes 0.000 description 17
• 101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 description 16
• 102100026018 Interleukin-1 receptor antagonist protein Human genes 0.000 description 16
• 238000010586 diagram Methods 0.000 description 15
• 210000002950 fibroblast Anatomy 0.000 description 15
• 238000011282 treatment Methods 0.000 description 15
• 125000003275 alpha amino acid group Chemical group 0.000 description 13
• 230000005945 translocation Effects 0.000 description 12
• 102100024108 Dystrophin Human genes 0.000 description 11
• 102100038614 Hemoglobin subunit gamma-1 Human genes 0.000 description 11
• 102100038617 Hemoglobin subunit gamma-2 Human genes 0.000 description 11
• 101001031977 Homo sapiens Hemoglobin subunit gamma-1 Proteins 0.000 description 11
• 108090000765 processed proteins & peptides Proteins 0.000 description 11
• 238000001890 transfection Methods 0.000 description 11
• 108010077544 Chromatin Proteins 0.000 description 10
• 102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 10
• 210000003483 chromatin Anatomy 0.000 description 10
• 239000013612 plasmid Substances 0.000 description 10
• 230000008439 repair process Effects 0.000 description 10
• 230000001629 suppression Effects 0.000 description 10
• 238000011529 RT qPCR Methods 0.000 description 9
• 101000910035 Streptococcus pyogenes serotype M1 CRISPR-associated endonuclease Cas9/Csn1 Proteins 0.000 description 9
• 102000057878 human DMD Human genes 0.000 description 9
• 210000002569 neuron Anatomy 0.000 description 9
• 238000013518 transcription Methods 0.000 description 9
• 230000035897 transcription Effects 0.000 description 9
• 238000010361 transduction Methods 0.000 description 9
• 230000026683 transduction Effects 0.000 description 9
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 8
• 108091005886 Hemoglobin subunit gamma Proteins 0.000 description 8
• 101000572986 Homo sapiens POU domain, class 3, transcription factor 2 Proteins 0.000 description 8
• 108091023040 Transcription factor Proteins 0.000 description 8
• 102000040945 Transcription factor Human genes 0.000 description 8
• 238000003556 assay Methods 0.000 description 8
• 238000006243 chemical reaction Methods 0.000 description 8
• 238000012239 gene modification Methods 0.000 description 8
• 229920001184 polypeptide Polymers 0.000 description 8
• 102000004196 processed proteins & peptides Human genes 0.000 description 8
• 102000004169 proteins and genes Human genes 0.000 description 8
• 101150010353 Ascl1 gene Proteins 0.000 description 7
• 238000004458 analytical method Methods 0.000 description 7
• 210000000349 chromosome Anatomy 0.000 description 7
• 239000012636 effector Substances 0.000 description 7
• 239000003623 enhancer Substances 0.000 description 7
• 108060003196 globin Proteins 0.000 description 7
• 238000007480 sanger sequencing Methods 0.000 description 7
• -1 synthesis Substances 0.000 description 7
• 238000001262 western blot Methods 0.000 description 7
• 108020003589 5' Untranslated Regions Proteins 0.000 description 6
• 101001031961 Homo sapiens Hemoglobin subunit gamma-2 Proteins 0.000 description 6
• 241000713666 Lentivirus Species 0.000 description 6
• 241001529936 Murinae Species 0.000 description 6
• 239000002131 composite material Substances 0.000 description 6
• 230000004927 fusion Effects 0.000 description 6
• 230000001965 increasing effect Effects 0.000 description 6
• 230000001939 inductive effect Effects 0.000 description 6
• 230000035772 mutation Effects 0.000 description 6
• 230000004031 neuronal differentiation Effects 0.000 description 6
• 230000001105 regulatory effect Effects 0.000 description 6
• 238000003757 reverse transcription PCR Methods 0.000 description 6
• 108700024394 Exon Proteins 0.000 description 5
• 108091005904 Hemoglobin subunit beta Proteins 0.000 description 5
• 108091005879 Hemoglobin subunit epsilon Proteins 0.000 description 5
• 101000979001 Homo sapiens Methionine aminopeptidase 2 Proteins 0.000 description 5
• 101000969087 Homo sapiens Microtubule-associated protein 2 Proteins 0.000 description 5
• 101001023043 Homo sapiens Myoblast determination protein 1 Proteins 0.000 description 5
• 102100023174 Methionine aminopeptidase 2 Human genes 0.000 description 5
• 102100031623 Myelin transcription factor 1-like protein Human genes 0.000 description 5
• 102100035077 Myoblast determination protein 1 Human genes 0.000 description 5
• 101150059596 Myt1l gene Proteins 0.000 description 5
• 230000027455 binding Effects 0.000 description 5
• 238000003776 cleavage reaction Methods 0.000 description 5
• 238000012937 correction Methods 0.000 description 5
• 238000002474 experimental method Methods 0.000 description 5
• 230000010354 integration Effects 0.000 description 5
• 239000003550 marker Substances 0.000 description 5
• 239000002609 medium Substances 0.000 description 5
• 238000007857 nested PCR Methods 0.000 description 5
• 230000006780 non-homologous end joining Effects 0.000 description 5
• 230000007017 scission Effects 0.000 description 5
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
• 108091093088 Amplicon Proteins 0.000 description 4
• 230000033616 DNA repair Effects 0.000 description 4
• 206010020751 Hypersensitivity Diseases 0.000 description 4
• 108091028043 Nucleic acid sequence Proteins 0.000 description 4
• 238000010459 TALEN Methods 0.000 description 4
• 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 4
• 241000700605 Viruses Species 0.000 description 4
• 230000003321 amplification Effects 0.000 description 4
• 239000013604 expression vector Substances 0.000 description 4
• 238000003780 insertion Methods 0.000 description 4
• 230000037431 insertion Effects 0.000 description 4
• 108020004999 messenger RNA Proteins 0.000 description 4
• 238000003199 nucleic acid amplification method Methods 0.000 description 4
• 102220605874 Cytosolic arginine sensor for mTORC1 subunit 2_D10A_mutation Human genes 0.000 description 3
• 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
• HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 3
• 108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 description 3
• 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 description 3
• 101001076422 Homo sapiens Interleukin-1 receptor type 2 Proteins 0.000 description 3
• 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 description 3
• 102100039065 Interleukin-1 beta Human genes 0.000 description 3
• 102100026017 Interleukin-1 receptor type 2 Human genes 0.000 description 3
• 241000699666 Mus <mouse, genus> Species 0.000 description 3
• 108010029485 Protein Isoforms Proteins 0.000 description 3
• 102000001708 Protein Isoforms Human genes 0.000 description 3
• 238000003559 RNA-seq method Methods 0.000 description 3
• 102000005890 Spectrin Human genes 0.000 description 3
• 108010019965 Spectrin Proteins 0.000 description 3
• 108700009124 Transcription Initiation Site Proteins 0.000 description 3
• 108700019146 Transgenes Proteins 0.000 description 3
• 238000010162 Tukey test Methods 0.000 description 3
• 102100039037 Vascular endothelial growth factor A Human genes 0.000 description 3
• 108010017070 Zinc Finger Nucleases Proteins 0.000 description 3
• 150000001413 amino acids Chemical class 0.000 description 3
• 238000004113 cell culture Methods 0.000 description 3
• 238000004520 electroporation Methods 0.000 description 3
• 238000000684 flow cytometry Methods 0.000 description 3
• 230000005017 genetic modification Effects 0.000 description 3
• 235000013617 genetically modified food Nutrition 0.000 description 3
• 102000018146 globin Human genes 0.000 description 3
• 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
• 210000005260 human cell Anatomy 0.000 description 3
• 238000001727 in vivo Methods 0.000 description 3
• 230000006698 induction Effects 0.000 description 3
• 210000001087 myotubule Anatomy 0.000 description 3
• 238000011002 quantification Methods 0.000 description 3
• 239000000523 sample Substances 0.000 description 3
• 238000002054 transplantation Methods 0.000 description 3
• YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
• 102100021519 Hemoglobin subunit beta Human genes 0.000 description 2
• 102100030826 Hemoglobin subunit epsilon Human genes 0.000 description 2
• 108010033040 Histones Proteins 0.000 description 2
• 101000998139 Homo sapiens Interleukin-32 Proteins 0.000 description 2
• 101001000998 Homo sapiens Protein phosphatase 1 regulatory subunit 12C Proteins 0.000 description 2
• 102100033501 Interleukin-32 Human genes 0.000 description 2
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
• 241000699670 Mus sp. Species 0.000 description 2
• 102100035620 Protein phosphatase 1 regulatory subunit 12C Human genes 0.000 description 2
• 238000010240 RT-PCR analysis Methods 0.000 description 2
• 108700005075 Regulator Genes Proteins 0.000 description 2
• 235000011449 Rosa Nutrition 0.000 description 2
• 241000193996 Streptococcus pyogenes Species 0.000 description 2
• 210000000234 capsid Anatomy 0.000 description 2
• 230000006378 damage Effects 0.000 description 2
• 230000004069 differentiation Effects 0.000 description 2
• 230000005014 ectopic expression Effects 0.000 description 2
• 238000007848 endpoint PCR Methods 0.000 description 2
• 238000009396 hybridization Methods 0.000 description 2
• 238000010166 immunofluorescence Methods 0.000 description 2
• 208000015181 infectious disease Diseases 0.000 description 2
• 230000005764 inhibitory process Effects 0.000 description 2
• 108040001669 interleukin-1 receptor antagonist activity proteins Proteins 0.000 description 2
• 238000002955 isolation Methods 0.000 description 2
• 210000005036 nerve Anatomy 0.000 description 2
• 230000001537 neural effect Effects 0.000 description 2
• 230000009437 off-target effect Effects 0.000 description 2
• 101150027852 pou3f2 gene Proteins 0.000 description 2
• 230000008707 rearrangement Effects 0.000 description 2
• 230000004044 response Effects 0.000 description 2
• 238000012216 screening Methods 0.000 description 2
• 238000012163 sequencing technique Methods 0.000 description 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• 102000007469 Actins Human genes 0.000 description 1
• 108010085238 Actins Proteins 0.000 description 1
• 101150105099 BRN2 gene Proteins 0.000 description 1
• 238000011746 C57BL/6J (JAX™ mouse strain) Methods 0.000 description 1
• 101710172824 CRISPR-associated endonuclease Cas9 Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 238000001353 Chip-sequencing Methods 0.000 description 1
• 101710135281 DNA polymerase III PolC-type Proteins 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• 101150061681 GZF3 gene Proteins 0.000 description 1
• 208000034951 Genetic Translocation Diseases 0.000 description 1
• 101100007625 Homo sapiens CR1 gene Proteins 0.000 description 1
• 101100286712 Homo sapiens IL1RN gene Proteins 0.000 description 1
• 101000615488 Homo sapiens Methyl-CpG-binding domain protein 2 Proteins 0.000 description 1
• 102100034343 Integrase Human genes 0.000 description 1
• 108060001084 Luciferase Proteins 0.000 description 1
• 239000005089 Luciferase Substances 0.000 description 1
• 102100021299 Methyl-CpG-binding domain protein 2 Human genes 0.000 description 1
• 101100163882 Mus musculus Ascl1 gene Proteins 0.000 description 1
• 108091081548 Palindromic sequence Proteins 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 102100029462 Sodium-dependent lysophosphatidylcholine symporter 1 Human genes 0.000 description 1
• 101710185583 Sodium-dependent lysophosphatidylcholine symporter 1 Proteins 0.000 description 1
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 1
• 108091028113 Trans-activating crRNA Proteins 0.000 description 1
• 108010073062 Transcription Activator-Like Effectors Proteins 0.000 description 1
• 102100035100 Transcription factor p65 Human genes 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 230000004075 alteration Effects 0.000 description 1
• 230000015572 biosynthetic process Effects 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 230000024245 cell differentiation Effects 0.000 description 1
• 238000002659 cell therapy Methods 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 239000002299 complementary DNA Substances 0.000 description 1
• 231100000135 cytotoxicity Toxicity 0.000 description 1
• 230000003013 cytotoxicity Effects 0.000 description 1
• 238000002784 cytotoxicity assay Methods 0.000 description 1
• 231100000263 cytotoxicity test Toxicity 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000011559 double-strand break repair via nonhomologous end joining Effects 0.000 description 1
• 239000003814 drug Substances 0.000 description 1
• 230000002500 effect on skin Effects 0.000 description 1
• 230000004049 epigenetic modification Effects 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 239000000835 fiber Substances 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 239000012634 fragment Substances 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 102000054313 human ASCL1 Human genes 0.000 description 1
• 238000000338 in vitro Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 210000004263 induced pluripotent stem cell Anatomy 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 102000009634 interleukin-1 receptor antagonist activity proteins Human genes 0.000 description 1
• 239000000543 intermediate Substances 0.000 description 1
• 210000003141 lower extremity Anatomy 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 230000028161 membrane depolarization Effects 0.000 description 1
• 210000000663 muscle cell Anatomy 0.000 description 1
• 230000001114 myogenic effect Effects 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 102000039446 nucleic acids Human genes 0.000 description 1
• 108020004707 nucleic acids Proteins 0.000 description 1
• 150000007523 nucleic acids Chemical class 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 1
• 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 230000007115 recruitment Effects 0.000 description 1
• 230000001172 regenerating effect Effects 0.000 description 1
• 230000008672 reprogramming Effects 0.000 description 1
• 230000028327 secretion Effects 0.000 description 1
• 210000004683 skeletal myoblast Anatomy 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 125000001424 substituent group Chemical group 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 229940104230 thymidine Drugs 0.000 description 1
• 210000001519 tissue Anatomy 0.000 description 1
• 231100000331 toxic Toxicity 0.000 description 1
• 230000002588 toxic effect Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 230000037426 transcriptional repression Effects 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 230000003827 upregulation Effects 0.000 description 1
• 238000010200 validation analysis Methods 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1